Shopping Cart
Remove All
Your shopping cart is currently empty
Phenserine tartrate
Copy Product Info
😃Good
Catalog No. T89337Cas No. 156910-61-1
Alias (-)-Phenserine (+)-tartrate, (-)-Eseroline phenylcarbamate tartrate
Phenserine tartrate ((-)-Eseroline phenylcarbamate) is a derivative of Physostigmine and functions as an efficient, non-competitive, long-acting, and selective inhibitor of acetylcholinesterase (AChE). This compound reduces the formation of amyloid precursor protein (APP) and β-amyloid peptides (Aβ), potentially improving cognitive abilities and alleviating the progression of Alzheimers disease.
Phenserine tartrate
Copy Product Info😃Good
Catalog No. T89337Alias (-)-Phenserine (+)-tartrate, (-)-Eseroline phenylcarbamate tartrateCas No. 156910-61-1
Phenserine tartrate ((-)-Eseroline phenylcarbamate) is a derivative of Physostigmine and functions as an efficient, non-competitive, long-acting, and selective inhibitor of acetylcholinesterase (AChE). This compound reduces the formation of amyloid precursor protein (APP) and β-amyloid peptides (Aβ), potentially improving cognitive abilities and alleviating the progression of Alzheimers disease.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Phenserine tartrate ((-)-Eseroline phenylcarbamate) is a derivative of Physostigmine and functions as an efficient, non-competitive, long-acting, and selective inhibitor of acetylcholinesterase (AChE). This compound reduces the formation of amyloid precursor protein (APP) and β-amyloid peptides (Aβ), potentially improving cognitive abilities and alleviating the progression of Alzheimers disease. |
| In vitro | Phenserine, when administered at concentrations of 1-25 μM for 48 hours to CHO APP 751SW cells, demonstrates significant biological activity. Specifically, CHO APP 751SW cells treated with 10 μM of Phenserine exhibit an 18.6% reduction in cell viability, while a higher concentration of 25 μM results in a 51.4% decrease in APP levels. |
| In vivo | When administered intraperitoneally at doses of 1-4 mg/kg for a continuous period of four days, phenserine improves learning in spatial memory tasks where cholinergic function is impaired in male Fischer-344 rats. |
| Synonyms | (-)-Phenserine (+)-tartrate, (-)-Eseroline phenylcarbamate tartrate |
| Molecular Weight | 487.5 |
| Formula | C24H29N3O8 |
| Cas No. | 156910-61-1 |
| Smiles | [C@@H]([C@H](C(O)=O)O)(C(O)=O)O.C[C@]12C=3C(N(C)[C@]1(N(C)CC2)[H])=CC=C(OC(NC4=CC=CC=C4)=O)C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Phenserine tartrate | purchase Phenserine tartrate | Phenserine tartrate cost | order Phenserine tartrate | Phenserine tartrate chemical structure | Phenserine tartrate in vivo | Phenserine tartrate in vitro | Phenserine tartrate formula | Phenserine tartrate molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.